Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Genflow Biosciences plc

GENFF
Current price
0.042 USD 0 USD (0.00%)
Last closed 1.8 GBX
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange LSE
Capitalization 6 300 126 GBX
Yield for 12 month +12.50 %
1Y
3Y
5Y
10Y
15Y
GENFF
21.11.2021 - 28.11.2021

Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom. Address: 6 Heddon Street, London, United Kingdom, W1B 4BT

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

-9 711 744 GBX

Last Quarter

-9 711 744 GBX

Current Year

-103 525 GBX

Last Year

-12 979 GBX

Current Quarter

-9 773 936 GBX

Last Quarter

-9 711 744 GBX

Key Figures GENFF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 531 632 GBX
Operating Margin TTM -66.19 %
PE Ratio
Return On Assets TTM -58.66 %
PEG Ratio
Return On Equity TTM -118.88 %
Wall Street Target Price
Revenue TTM 598 555 GBX
Book Value 0.002 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 308.2 %
Dividend Yield
Gross Profit TTM
Earnings per share -0.01 GBX
Diluted Eps TTM -0.01 GBX
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin -256.07 %

Dividend Analytics GENFF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GENFF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GENFF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 10.5256
Enterprise Value EBITDA -0.564
Price Book MRQ 7.3336

Financials GENFF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GENFF

For 52 weeks

1.32 GBX 3.41 GBX
50 Day MA 2.07 GBX
Shares Short Prior Month
200 Day MA 2.03 GBX
Short Ratio
Shares Short
Short Percent